Fourteen patients with acute myocardial infarction were given 0.3 mg sublingual nitroglycerin within the first 12 hours of their acute myocardial infarction. Five minutes after sublingual nitroglycerin mean arterial pressurefell 9 mmHg (I.2 kPa) and remained significantly reducedfor 30 minutes. Pulmonary capillary wedge pressure fellfrom a mean control value of 17 to I2 mmHg (2.3 to i.6 kPa) and also remained reducedfor 30 minutes. Heart rate was significantly raised and stroke work index reduced at five minutes. Patients with a stroke work index of greater than 55 g m per m2 b.s.a. responded to nitroglycerin with a fall in both pulmonary capillary wedge pressure and stroke work index while in those with a stroke work index of less than 55 g m per m2 b.s.a. stroke work index did not fall concomitantly with the fall in pulmonary capillary wedge pressure. In one patient, nitroglycerin led to a precipitousfall in arterial pressure and recurrence of chest pain.
Nitroglycerin has been considered to be contraindicated in acute myocardial infarction because it may lower systemic blood pressure and cause a reflex rise in heart rate (Friedberg, I966) . Recent work has, however, suggested that vasodilator drugs may be useful in the therapy of myocardial infarction, as pump performance may be improved while at the same time myocardial oxygen demand is decreased (Franciosa et al., 1972; Kelly et al., 1973) . These studies have renewed interest in nitroglycerin therapy in acute myocardial infarction. In experimental animals with acute myocardial infarction, intravenous nitroglycerin has been shown to decrease the area of ischaemia as assessed by ST segment mapping (Smith et al., 1973) . Gold, Leinbach, and Sanders (1972) have given sublingual nitroglycerin to patients within a week after myocardial infarction and found that left ventricular function improved in patients with congestive failure but remained unchanged in those without significant heart failure. The purpose of this report is to examine the haemodynamic response to sublingual nitroglycerin during the early hours after myocardial infarction and to assess its role in the early therapy of patients with acute myocardial infarction. 
Subjects
Fourteen patients with acute myocardial infarction were studied at an average time of 8 hours (range 4 to I4 hours) after the onset of symptoms. The average age of the patients was 57.9 years, 8 were men and 6 were women; IO white and 4 black. Two patients had subendocardial myocardial infarction and 12 transmural infarction of which 8 were inferior and 6 anterior. All patients had raised serum creatine phosphokinase enzymes. Two patients had had a previous myocardial infarction; 2 had chronic angina pectoris; 5 had a history of hypertension, but none was receiving treatment for it, and one patient had chronic congestive heart failure. The 14 patients were clinically classified according to the Killip Classification (Killip, I968); 7 patients were in Class I, with uncomplicated myocardial infarction; and 7 in Class II, with clinical or radiological signs of early left ventricular failure. All patients had received oxygen, narcotics when indicated for pain, and lignocaine for ventricular arrhythmias when indicated, but no inotropic drugs or diuretics were administered before nitroglycerin. The procedure was explained to the patients and informed consent obtained. (Forrester et al., 1972 ) using a Swan-Ganz thermodilution catheter (Edwards Laboratories, Model No. 93-II3-7F) and 5 ml room-temperature injectate introduced into the right atrium. The accuracy of this system had been previously compared with direct Fick measurements; the average of two thermodilution cardiac outputs had a standard error of ± 4 per cent of the cardiac output as determined by the Fick method (Komer et al., I973). In this laboratory the average of two thermodilution cardiac outputs was compared simultaneously with two indocyanine green dye curves in a group of io patients after acute myocardial infarction; the linear regression did not differ significantly from the line of identity and the correlation was 0.93.
Methods
The figures for cardiac output in the study represent the mean of two sequential determinations in 73 of the 83 outputs determined. The remaining I0 were calculated from one injection of saline. The linear regression of the plot of the two determinations had a slope of 0.95 and did not differ significantly from the line of identity. The correlation was 0.93.
Control measurements of pulmonary artery wedge pressure, arterial pressure, and cardiac output were made and repeated after 20 minutes. Since there were no significant differences during the control period for any of the variables measured (Fig. I) The relation of stroke work index to pulmonary capillary wedge pressure is shown in Fig. 3 at the peak effect of sublingual nitroglycerin on pulmonary capillary wedge pressure. On the basis of this relation, the patients were arbitrarily divided into two subgroups. There were 6 patients with a stroke work index of greater than 55 g m per m2 b. Discussion Sublingual nitroglycerin resulted in a significant fall in pulmonary capillary wedge pressure in I4 patients studied within 12 hours of onset of symptoms of myocardial infarction in the present study. There were, however, significant differences in the response in those patients with a stroke work index greater than (group i) and less than (group 2) 55 g m per m2 b.s.a.
In group i patients nitroglycerin resulted in a significant fall in both pulmonary capillary wedge pressure and stroke work index. This response is similar to that seen with a diuretic (Kiely et al., I973) and is caused by a reduction in venous return caused by peripheral venous pooling (Mason and Braunwald, I965) . Since the pulmonary congestion in group i patients is probably at least in part caused by a reduction in left ventricular compliance (Diamond and Forrester, I972) , it is not surprising that small changes in venous return, either by nitroglycerin or a diuretic, cause a significant fall in pulmonary capillary wedge pressure. Since the In addition to its possible haemodynamic benefits, nitroglycerin has also been shown to reduce myocardial oxygen requirements and infarct size in experimental animals (Smith et al., 1973) . While it is possible that the area of myocardial ischaemia may have decreased after the administration of sublingual nitroglycerin because of a direct effect upon the coronary circulation, as suggested in animals after intravenous nitroglycerin (Smith et al., I973), this effect may only be transient, as the haemodynamic effects of sublingual nitroglycerin last less than 30 minutes. To affect infarct size significantly, a longer effect would be desirable, such as obtained with intravenous nitroglycerin. In contrast to the possible beneficial effects, there is also a potential risk that the area of ischaemia could actually be increased after sublingual nitroglycerin. This was suggested by one of our patients in group 2 with pulmonary congestion (Fig. 2) who had an abrupt decrease in systemic pressure after sublingual nitroglycerin in association with the recurrence of praecordial chest pain. The level of diastolic pressure has been shown to be a major determinant of coronary perfusion. In patients with acute myocardial infarction where a tenuous balance already exists between myocardial oxygen supply and demands, any large decrease in coronary perfusion pressure may result in further ischaemia and infarct extension. We would, therefore, recommend that diuretics such as frusemide continue to be used as the primary therapeutic agent in patients with mild to moderate pulmonary congestion complicating their infarction and that sublingual nitroglycerin be reserved for those patients who fail to improve after a diuretic (Kiely et 
